Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Palatin Technologies 

Cedar Brook Corporate Center
4C Cedar Brook Drive
Cranbury  New Jersey  08512  U.S.A.
Phone: 609-495-2200 Fax: 609-495-2201


 Company News
Palatin Technologies (PTN) Announces Start Of Bremelanotide Phase 3 Program For Female Sexual Dysfunction 12/29/2014 7:44:00 AM
Palatin Technologies (PTN) Completes $20 Million Equity And $10 Million Debt Financings 12/24/2014 7:28:28 AM
Palatin Technologies (PTN) Reports First Quarter Fiscal Year 2015 Results; Teleconference And Webcast To Be Held On November 18, 2014 11/18/2014 11:05:25 AM
Palatin Technologies (PTN) To Report First Quarter Fiscal Year 2015 Results 11/14/2014 7:48:15 AM
Palatin Technologies (PTN) Release: Survey Reveals Low Sexual Desire Disrupts Relationships 11/4/2014 9:19:24 AM
Palatin Technologies (PTN) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/8/2014 8:29:29 AM
Palatin Technologies (PTN) Reports Fourth Quarter And Fiscal Year End 2014 Results 9/9/2014 8:48:23 AM
Palatin Technologies (PTN) To Report Fourth Quarter And Fiscal Year 2014 Results 9/5/2014 10:49:21 AM
Palatin Technologies (PTN) Licenses Bremelanotide In Europe And Other Selected Countries To Gedeon Richter Ltd. (RIG2.F) 9/3/2014 11:35:30 AM
Palatin Technologies (PTN) Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides 7/9/2014 9:40:46 AM